Search clinical trials for: Palbociclib Letrozole
Total 938 results
-
PfizerCompletedBreast CancerAustralia, India
-
University of NebraskaRecruitingClinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine TherapyBreast CancerUnited States
-
PfizerRecruitingBreast NeoplasmsAustria, Germany
-
Royal Marsden NHS Foundation TrustPfizer; Roche Pharma AG; Institute of Cancer Research, United KingdomUnknownBreast Cancer | Advanced Solid TumoursUnited Kingdom
-
InventisBio Co., LtdCompleted
-
PfizerActive, not recruitingBreast NeoplasmsChina, Taiwan, Hong Kong, Singapore, Thailand
-
Helsinki University Central HospitalFoundation for Paediatric Research, FinlandCompletedConstitutional Delay of Growth and PubertyFinland
-
PfizerCompleted
-
Fundacion OncosurPfizer; Apices Soluciones S.L.; Pierre Fabre Ibérica, S.A.CompletedTriple Negative Breast CancerSpain
-
Grupo Espanol de Tumores NeuroendocrinosCompleted
-
University of Milano BicoccaCompleted
-
Razelle Kurzrock, MDWithdrawnCancer, AdvancedUnited States
-
AstraZenecaRecruitingER-Positive HER2-Negative Breast CancerUnited States, Israel, Spain, Korea, Republic of, Italy, Poland, Belgium, Norway, Bulgaria, France, Germany, United Kingdom, Japan, Taiwan, Canada, Hungary, Australia, Austria, Portugal, Turkey, Russian Federation, Slovakia, Switzer...
-
PfizerCompletedAdvanced Breast Cancer FemaleMexico, Argentina, Brazil, Colombia
-
Northwestern UniversityNational Cancer Institute (NCI)Not yet recruitingMetastatic Breast Cancer | Estrogen-receptor-positive Breast Cancer | HER2/Neu-Negative Breast Cancer | Advanced Breast CancervUnited States
-
Brown UniversityTaiho Oncology, Inc.RecruitingSoft Tissue Sarcoma | Advanced Breast Cancer | SCLC | Bladder Cancer | Endometrial Cancer | Treatment-Refractory Solid Tumors | Retinoblastoma DeficiencyUnited States
-
PfizerCompleted
-
National Taiwan University HospitalRecruitingBreast Cancer | Hormone Receptor-positive Breast Cancer | Hormone TherapyTaiwan
-
PfizerCompletedBreast NeoplasmsUnited States, Canada, Spain, United Kingdom, Australia, Belgium, Korea, Republic of, Japan, Czechia, France, Germany, Hungary, Ireland, Italy, Poland, Russian Federation, Taiwan, Ukraine
-
German Breast GroupPfizer; AGO Study Group; Breast International Group; NSABP Foundation IncCompletedBreast Cancer | Hormonreceptor Positive | Her2-normal | Postneoadjuvant Treatment With CDK 4/6 Inhibitor | CPS-EG ScoreUnited States, Australia, Austria, Canada, France, Germany, Ireland, Japan, Korea, Republic of, Spain, United Kingdom
-
Namik Kemal UniversityNot yet recruitingCan the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 InhibitorsTurkey
-
NiKang Therapeutics, Inc.PfizerRecruitingNeoplasms | Kidney Cancer | Kidney Neoplasms | Carcinoma, Renal Cell | Urologic Neoplasms | Urogenital Neoplasms | Neoplasms by Site | Kidney Diseases | Urologic Diseases | Adenocarcinoma | Carcinoma | Neoplasms, Glandular and Epithelial | Clear Cell Renal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Recurrent... and other conditionsUnited States
-
PfizerCompleted
-
Rovi Pharmaceuticals LaboratoriesRecruiting
-
Maastricht University Medical CenterNetherlands Thrombosis FoundationCompletedDeep Vein ThrombosisNetherlands
-
SOLTI Breast Cancer Research GroupPfizerCompleted
-
Royal Marsden NHS Foundation TrustPfizer; AstraZeneca; Institute of Cancer Research, United Kingdom; UNICANCER; Gustave... and other collaboratorsRecruitingHER2-negative Breast Cancer | ER+ Breast CancerUnited Kingdom, France
-
Institut du Cancer de Montpellier - Val d'AurelleNovartisCompleted
-
Arvinas Estrogen Receptor, Inc.PfizerActive, not recruiting
-
Calithera Biosciences, IncCompletedNSCLC | Solid Tumors | KRAS Gene Mutation | CRCUnited States
-
Washington University School of MedicinePfizerCompletedCarcinoma, Squamous Cell of Head and NeckUnited States
-
Haukeland University HospitalPfizer; AstraZeneca; Helse VestActive, not recruitingBreast CancerNorway
-
German Breast GroupPfizer; AMS Advanced Medical Services GmbHRecruitingMetastatic Breast CancerGermany
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
University of Alabama at BirminghamGenentech, Inc.; Breast Cancer Research FoundationCompletedBreast Cancer | Breast Neoplasm | Cancer of the BreastUnited States
-
Haihe Biopharma Co., Ltd.Not yet recruiting
-
PfizerArvinas Estrogen Receptor, Inc.Active, not recruitingBreast CancerSpain, United States, China, Japan, Australia, Italy, Switzerland, Hungary, Brazil, Slovakia
-
PfizerActive, not recruiting
-
Eisai Inc.Active, not recruitingBreast Neoplasms | Receptors, Estrogen | Genes, Erbb-2United States, United Kingdom
-
ETOP IBCSG Partners FoundationPfizerRecruitingBreast Cancer RecurrentSwitzerland, Italy, France, Spain, Hungary, Austria
-
National Cancer Institute (NCI)RecruitingAdvanced Clear Cell Renal Carcinoma (Ccrcc) | Papillary Renal Cell Carcinoma (Prcc)United States
-
PfizerCompletedMetastatic Breast CancerSpain, Belgium, Sweden, United Kingdom, Austria, Germany, Switzerland
-
PfizerCompletedSquamous Cell Carcinoma of the Head and Neck (SCCHN)United States, Spain, Korea, Republic of, Czechia, Taiwan, Serbia, Japan, Slovakia, Mexico, Romania, Hungary, Italy, Poland, Russian Federation, Ukraine
-
Forward Pharmaceuticals Co., Ltd.RecruitingMetastatic Breast Cancer | Breast Cancer Stage I | Locally Advanced Breast Cancer | ER+ Breast CancerChina
-
Wyeth is now a wholly owned subsidiary of PfizerPfizerCompletedBreast Neoplasms
-
IVI MadridActive, not recruitingLuteinised Follicular CystSpain
-
Assiut UniversityRecruitingInfertility, FemaleEgypt
-
Fudan UniversityRecruitingEndometrial CancerChina
-
MedSIRCompletedMetastatic Breast CancerSpain, Czechia, France, Germany, Italy, Russian Federation, United Kingdom